查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1701234

伴同性诊断市场规模、份额、趋势分析报告：按产品/服务、适应症、技术、产品类型、最终用途、地区、细分市场预测，2025-2030 年

Companion Diagnostics Market Size, Share & Trends Analysis Report By Product And Services, By Indication, By Technology, By Sample Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

伴同性诊断市场的成长与趋势

根据 Grand View Research, Inc. 的新报告，全球伴同性诊断市场规模预计到 2030 年将达到 159.8 亿美元，2025-2030 年期间的复合年增长率为 10.5%。

伴同性诊断是一种专门的测试，旨在透过识别患者体内相应的生物标记来确保特定治疗的安全有效使用。这些测试主要用于肿瘤学，以指导临床医生根据患者独特的基因特征选择最合适的标靶治疗。例如，Foundation Medicine 的 FOUNDATIONONE CDx 分析了 300 多个癌症相关基因，并提供了可为一系列固体癌的精准癌症治疗提供资讯的关键见解。伴同性诊断可以透过识别重要的突变或基因改变来促进个人化治疗方法，从而改善临床结果并降低副作用的风险。这种个人化的治疗方法不仅可以改善患者的护理，而且还支持向精准医疗的更广泛转变，其中治疗策略根据每个患者独特的基因组成量身定制。

监管部门的核准在伴同性诊断市场中起着至关重要的作用，尤其是在肿瘤学领域。 2022年8月，美国FDA核准了赛默飞世尔科技的Oncomine Dx Target Test。此伴同性诊断旨在识别非小细胞肺癌肿瘤中的 HER2（ERBB2）活化突变，包括单核苷酸变异和外显子 20 插入。此类监管部门的核准将检验这些测试的临床效用并促进其广泛使用。此外，使用次世代定序（NGS）等先进技术对于伴同性诊断至关重要。 NGS 允许临床医生同时评估多个基因，从而描述全面的肿瘤分析。美国疾病管制与预防中心 (CDC) 强调，NGS 在过去五年内已成功从研究工具转变为临床核准的方法，凸显了其在诊断应用中日益增长的重要性。

技术创新是伴同性诊断市场成长的关键驱动力。主要行业参与企业正在不断发展其 NGS 平台、数位 ELISA 和液态切片技术，以提高诊断的准确性和效率。例如，2023 年 11 月，QIAGEN 与 Element Biosciences 合作，在其 AVITI 桌上型定序仪系统上提供 NGS 工作流程，旨在增强发现、降低成本并加快基因组研究的周转时间。同样，2022 年 1 月，Illumina 与 SomaLogic Operating Co., Inc. 合作，将 SomaScan 蛋白质组学检测整合到其高通量 NGS 平台中。这些合作不仅扩展了伴同性诊断的技术能力，而且促进了新检测解决方案开发的创新，并确保新的诊断方法能够满足不断变化的临床需求。

全球癌症发生率的不断上升是伴同性诊断应用的重要推动因素。基因组检测提供了对肿瘤生物学的详细了解，这对于选择有效的治疗通讯协定至关重要。根据《美国癌症杂誌》的资料，2022年美国将通报约190万例新发癌症病例，而世界卫生组织（WHO）指出，同年全球将通报226万例新乳癌病例和221万例新发肺癌病例。为了应对这些挑战，正在开发检测特定基因突变的新测试。例如，2020年8月，美国FDA核准了Guardant360 CDx，这是第一个使用NGS技术检测转移性非小细胞肺癌EGFR基因突变的液态切片伴同性诊断。 2023 年 10 月，QIAGEN 与 Myriad Genetics 合作开发肿瘤学领域的先进伴同性诊断解决方案，以增强个人化治疗策略并改善患者预后，进一步巩固了其市场地位。

伴同性诊断市场报告重点

  • 按产品和服务划分，到 2024 年，检测、套件和试剂将占据 59.1% 的市场份额，引领市场。这些组件对于检测特定生物标记至关重要，有助于确定患者合格精准治疗，尤其是在肿瘤学、心血管疾病和罕见遗传疾病领域。
  • 从适应症来看，由于全球癌症发生率的上升和个人化医疗需求的不断增长，预计到 2024 年肿瘤学将占据绝对的市场占有率。 CDx 在识别有助于选择标靶治疗和改善癌症患者预后的生物标记方面发挥关键作用。
  • 基于技术，聚合酵素链锁反应(PCR) 领域在 2024 年占据伴同性诊断市场的主导地位，占有 27.7% 的份额。即时PCR因其高特异性和敏感性而被广泛应用，使其成为识别癌症生物标记的首选方法。
  • 根据样本类型，组织样本将在 2024 年占据最大的市场占有率，达到 62.7%，这得益于基于生物标记的组织检测在标靶治疗中的广泛应用。组织样本对于识别固态肿瘤中的基因突变和蛋白质表现至关重要，可以指导肿瘤学的精准医疗。
  • 根据最终用途，医院和医生检测部门将主导癌症伴同性诊断市场，到 2024 年将占 38.6% 的份额。医院通常提供全面的癌症诊断测试​​，以应对日益加重的癌症负担和人口老化问题。
  • 2024 年，北美占据全球市场主导地位，市场占有率为 40.2%。主要原因是先进的医疗基础设施、高昂的医疗支出以及加快新诊断技术核准的强有力的法律规范。

目录

第一章调查方法与范围

第二章执行摘要

第三章伴同性诊断市场变数、趋势和范围

  • 市场介绍/电网展望
  • 市场规模和成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 伴同性诊断市场分析工具
    • 波特分析
    • PESTEL分析
    • 管道
    • 使用案例

第四章伴同性诊断市场：按产品和服务的估计和趋势分析

  • 细分仪表板
  • 伴同性诊断市场：2024 年与 2030 年产品与服务趋势分析
  • 检测试剂套件和试剂
  • 设备和系统
  • 软体和服务

第五章伴同性诊断市场：按适应症的估计与趋势分析

  • 细分仪表板
  • 伴同性诊断市场：2024 年和 2030 年适应症变化分析
  • 肿瘤学
  • 感染疾病
  • 心血管疾病
  • 神经系统疾病
  • 其他的

第六章伴同性诊断市场：依技术、估计和趋势分析

  • 细分仪表板
  • 伴同性诊断市场：2024 年和 2030 年技术变革分析
  • 聚合酵素链锁反应（PCR）
  • 下一代定序（NGS）
  • 原位杂合反应（ISH）
  • 免疫组织化学（IHC）
  • 磁振造影（MRI）
  • 其他的

第七章伴同性诊断市场：依样本类型估算与趋势分析

  • 细分仪表板
  • 伴同性诊断市场：样本类型变异分析，2024 年 vs 2030 年
  • 组织样本
  • 血液样本
  • 其他的

第八章伴同性诊断市场：按最终用途的估计和趋势分析

  • 细分仪表板
  • 伴同性诊断市场：2024 年与 2030 年最终用途趋势分析
  • 学术研究中心
  • 医院和医生检查室
  • CRO
  • 参考实验室
  • 製药和生物技术公司
  • 其他的

第九章伴同性诊断市场：区域、估计和趋势分析

  • 2024 年及 2030 年伴同性诊断市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 公司热图分析
  • 公司简介
    • QIAGEN
    • Agilent Technologies, Inc.
    • Abbott
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann La Roche Ltd
    • Foundation Medicine
    • Myriad Genetics
    • Illumina, Inc.
Product Code: GVR-4-68040-536-9

Companion Diagnostics Market Growth & Trends:

The global companion diagnostics market size is expected to reach USD 15.98 billion by 2030, registering a CAGR of 10.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. Companion diagnostics are specialized tests designed to ensure the safe and effective use of specific therapeutic products by identifying corresponding biomarkers in patients. These tests are predominantly employed in oncology, where they guide clinicians in selecting the most appropriate targeted therapies based on a patient's unique genetic profile. For instance, Foundation Medicine's FOUNDATIONONE CDx analyzes over 300 cancer-related genes, providing critical insights that inform precision cancer treatments across various solid tumors. By identifying key mutations or genetic alterations, companion diagnostics facilitate personalized treatment regimens, thereby improving clinical outcomes and reducing the risk of adverse reactions. This individualized approach to therapy not only enhances patient care but also supports the broader shift towards precision medicine, where treatment strategies are tailored to the genetic makeup of each patient.

Regulatory approvals play a pivotal role in bolstering the companion diagnostics market, particularly in oncology. In August 2022, the U.S. FDA approved Thermo Fisher Scientific Inc.'s Oncomine Dx Target Test, a companion diagnostic designed to identify HER2 (ERBB2) activating mutations-including single nucleotide variants and exon 20 insertions-in non-small cell lung cancer tumors. Such regulatory endorsements validate the clinical utility of these tests and promote their widespread adoption. Additionally, the use of advanced techniques such as Next-Generation Sequencing (NGS) has become integral to companion diagnostics. NGS enables clinicians to evaluate multiple genes simultaneously, thereby providing comprehensive tumor profiling. The Centers for Disease Control and Prevention (CDC) has highlighted that NGS has successfully transitioned from a research tool to a clinically approved method within the past five years, underscoring its growing importance in diagnostic applications.

Technological innovation is a critical driver of growth in the companion diagnostics market. Key industry players are continuously advancing NGS platforms, digital ELISA, and liquid biopsy techniques to improve diagnostic precision and efficiency. Strategic partnerships are further accelerating these developments; for instance, in November 2023, QIAGEN partnered with Element Biosciences to provide NGS workflows for the benchtop sequencer AVITI System, aiming to enhance discovery, reduce costs, and improve turnaround times in genomic research. Similarly, in January 2022, Illumina Inc. collaborated with SomaLogic Operating Co., Inc. to integrate the SomaScan proteomics assay into its high-throughput NGS platforms. These collaborations not only expand the technological capabilities of companion diagnostics but also foster innovation in the development of new testing solutions, ensuring that emerging diagnostic methods keep pace with evolving clinical needs.

The rising prevalence of cancer globally has significantly spurred the adoption of companion diagnostics, as genomic testing offers a detailed insight into tumor biology that is critical for selecting effective treatment protocols. According to data from the American Cancer Society Journal, approximately 1.9 million new cancer cases were reported in the U.S. in 2022, while the World Health Organization (WHO) noted that in the same year, there were 2.26 million new breast cancer cases and 2.21 million new lung cancer cases worldwide. In response to these challenges, novel tests are being developed to detect specific genetic mutations. For example, in August 2020, the U.S. FDA approved Guardant360 CDx, the first liquid biopsy companion diagnostic that employs NGS technology to detect EGFR gene mutations in metastatic non-small cell lung cancer. In October 2023, QIAGEN further strengthened its market position by partnering with Myriad Genetics to develop advanced companion diagnostic solutions for oncology, thereby enhancing personalized treatment strategies and improving patient outcomes.

Companion Diagnostics Market Report Highlights:

  • Based on product and services segment, assays, kits, and reagents led the market with a 59.1% share in 2024, driven by increasing demand for personalized medicine and targeted therapies. These components are crucial in detecting specific biomarkers that help determine a patient's eligibility for precision treatments, particularly in oncology, cardiovascular diseases, and rare genetic disorders.
  • Based on indication, oncology held the dominant market share in 2024, driven by the increasing global cancer burden and the growing demand for personalized medicine. CDx plays a crucial role in identifying biomarkers that help select targeted therapies, improving treatment outcomes for cancer patients.
  • Based on technology, the Polymerase Chain Reaction (PCR) segment dominated the companion diagnostics market in 2024, holding a 27.7% share. Real-time PCR assays are widely used due to their high specificity and sensitivity, making them a preferred method for identifying cancer biomarkers
  • Based on sample type, tissue samples held the largest market share of 62.7% in 2024, driven by the widespread adoption of biomarker-based tissue testing for targeted therapies. Tissue samples are essential for identifying genetic mutations and protein expressions in solid tumors, guiding precision medicine in oncology.
  • Based on end use, the hospitals and physician laboratories segment dominated the oncology companion diagnostics market, holding a 38.6% share in 2024. Hospitals typically offer a comprehensive range of cancer diagnostic tests to address the increasing cancer burden and aging populations.
  • North America dominated the global market with a market share of 40.2% in 2024. Primarily due to advanced healthcare infrastructure, substantial healthcare expenditure, and a robust regulatory framework that expedites approvals for new diagnostic technologies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Companion Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Companion Diagnostics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape
    • 3.4.3. Pipeline
    • 3.4.4. Case Study

Chapter 4. Companion Diagnostics Market: Product and Services Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Companion Diagnostics Market: Product and Services Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Assays, Kits, and Reagents
    • 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Instruments and Systems
    • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Software and Services
    • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Companion Diagnostics Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Companion Diagnostics Market: Indication Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. Oncology
    • 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Infectious Diseases
    • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cardiovascular Diseases
    • 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Neurological Disorders
    • 5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Other Indications
    • 5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Companion Diagnostics Market: Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Companion Diagnostics Market: Sample Type Movement Analysis, 2024 & 2030 (USD Million)
  • 6.3. Polymerase Chain Reaction (PCR)
    • 6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Next-generation Sequencing (NGS)
    • 6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. In-situ Hybridisation (ISH)
    • 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Immunohistochemistry (IHC)
    • 6.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Magnetic Resonance Imaging (MRI)
    • 6.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Other Technology
    • 6.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Companion Diagnostics Market: Sample Type Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Companion Diagnostics Market: Sample Type Movement Analysis, 2024 & 2030 (USD Million)
  • 7.3. Tissue Samples
    • 7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Blood Samples
    • 7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Other Sample Types
    • 7.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Companion Diagnostics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Companion Diagnostics Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
  • 8.3. Academic and Research Centers
    • 8.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Hospitals and Physician Laboratories
    • 8.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. CROs
    • 8.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Reference Laboratories
    • 8.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Pharmaceutical and Biotechnology Companies
    • 8.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Other End-use
    • 8.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Companion Diagnostics Market: Regional Estimates & Trend Analysis

  • 9.1. Companion Diagnostics Market Share, By Region, 2024 & 2030 (USD Million)
  • 9.2. North America
    • 9.2.1. North America Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. U.S. Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Canada Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Mexico Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. UK Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Germany Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. France Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Italy Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Spain Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Denmark Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Sweden Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Norway Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Japan Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. China Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. India Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Australia Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.6. South Korea
      • 9.4.6.1. South Korea Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Thailand Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Brazil Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Argentina Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. South Africa Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. South Africa Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. UAE Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Kuwait Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Company Heat Map Analysis
  • 10.4. Company Profiles
    • 10.4.1. QIAGEN
      • 10.4.1.1. Participant's Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product and Services Benchmarking
      • 10.4.1.4. Recent Developments/ Strategic Initiatives
    • 10.4.2. Agilent Technologies, Inc.
      • 10.4.2.1. Participant's Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product and Services Benchmarking
      • 10.4.2.4. Recent Developments/ Strategic Initiatives
    • 10.4.3. Abbott
      • 10.4.3.1. Participant's Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product and Services Benchmarking
      • 10.4.3.4. Recent Developments/ Strategic Initiatives
    • 10.4.4. Thermo Fisher Scientific, Inc.
      • 10.4.4.1. Participant's Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product and Services Benchmarking
      • 10.4.4.4. Recent Developments/ Strategic Initiatives
    • 10.4.5. F. Hoffmann La Roche Ltd
      • 10.4.5.1. Participant's Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product and Services Benchmarking
      • 10.4.5.4. Recent Developments/ Strategic Initiatives
    • 10.4.6. Foundation Medicine
      • 10.4.6.1. Participant's Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product and Services Benchmarking
      • 10.4.6.4. Recent Developments/ Strategic Initiatives
    • 10.4.7. Myriad Genetics
      • 10.4.7.1. Participant's Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product and Services Benchmarking
      • 10.4.7.4. Recent Developments/ Strategic Initiatives
    • 10.4.8. Illumina, Inc.
      • 10.4.8.1. Participant's Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product and Services Benchmarking
      • 10.4.8.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global companion diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 4 Global companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 5 Global companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 6 Global companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 7 Global companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 North America companion diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 10 North America companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 11 North America companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 12 North America companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 13 North America companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 U.S. companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 15 U.S. companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 16 U.S. companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 17 U.S. companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 18 U.S. companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Canada companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 20 Canada companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 21 Canada companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Canada companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 23 Canada companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Mexico companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 25 Mexico companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 26 Mexico companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Mexico companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 28 Mexico companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Europe companion diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 30 Europe companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 31 Europe companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 32 Europe companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Europe companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 34 Europe companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 UK companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 36 UK companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 37 UK companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 38 UK companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 39 UK companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Germany companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 41 Germany companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 42 Germany companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Germany companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 44 Germany companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 France companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 46 France companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 47 France companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 48 France companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 49 France companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Italy companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 51 Italy companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 52 Italy companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 53 Italy companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 54 Italy companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Spain companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 56 Spain companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 57 Spain companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Spain companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 59 Spain companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Denmark companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 61 Denmark companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 62 Denmark companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 63 Denmark companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 64 Denmark companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Sweden companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 66 Sweden companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 67 Sweden companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Sweden companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 69 Sweden companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 Norway companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 71 Norway companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 72 Norway companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 73 Norway companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 74 Norway companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific companion diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 81 Japan companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 82 Japan companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 83 Japan companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Japan companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 85 Japan companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 China companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 87 China companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 88 China companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 89 China companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 90 China companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 91 India companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 92 India companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 93 India companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 94 India companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 95 India companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 96 Australia companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 97 Australia companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 98 Australia companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 99 Australia companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 100 Australia companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 101 South Korea companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 102 South Korea companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 103 South Korea companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 104 South Korea companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 105 South Korea companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 106 Thailand companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 107 Thailand companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 108 Thailand companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 109 Thailand companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 110 Thailand companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 111 Latin America companion diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 112 Latin America companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 113 Latin America companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 114 Latin America companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 115 Latin America companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 116 Latin America companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 117 Brazil companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 118 Brazil companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 119 Brazil companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 120 Brazil companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 121 Brazil companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 122 Argentina companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 123 Argentina companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 124 Argentina companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 125 Argentina companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 126 Argentina companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 127 MEA companion diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 128 MEA companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 129 MEA companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 130 MEA companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 131 MEA companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 132 MEA companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 133 South Africa companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 134 South Africa companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 135 South Africa companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 136 South Africa companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 137 South Africa companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 143 UAE companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 144 UAE companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 145 UAE companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 146 UAE companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 147 UAE companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 148 Kuwait companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 149 Kuwait companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 150 Kuwait companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 151 Kuwait companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 152 Kuwait companion diagnostics market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Companion Diagnostics market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot - 1
  • Fig. 14 Segment snapshot - 2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Companion Diagnostics market: Product and Services outlook key takeaways
  • Fig. 20 Companion Diagnostics market: Product and Services movement analysis
  • Fig. 21 Assays, kits, and reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Instruments and systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Software and services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Companion Diagnostics market: Indication outlook key takeaways
  • Fig. 25 Companion Diagnostics market: Indication movement analysis
  • Fig. 26 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Infectious diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Cardiovascular diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Neurological disorders market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Other Indications market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Companion Diagnostics market: Technology outlook key takeaways
  • Fig. 32 Companion Diagnostics market: Technology movement analysis
  • Fig. 33 Polymerase Chain Reaction (PCR) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Next-generation Sequencing (NGS) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 In-situ Hybridisation (ISH) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Immunohistochemistry (IHC) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Magnetic Resonance Imaging (MRI) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Other technology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Companion Diagnostics market: Sample Type outlook key takeaways
  • Fig. 40 Companion Diagnostics market: Sample Type movement analysis
  • Fig. 41 Tissue samples market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Blood samples market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Other sample types market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Companion Diagnostics market: End-use outlook key takeaways
  • Fig. 45 Companion Diagnostics market: End-use movement analysis
  • Fig. 46 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Diagnostics Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Academic and Research Centers
  • Fig. 50 Hospitals and Physician Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 CROs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Reference Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Pharmaceutical and Biotechnology Companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Other End-use market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Regional marketplace outlook, 2024 & 2030 (USD Million)
  • Fig. 56 Regional marketplace: Key takeaways
  • Fig. 57 North America companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 U.S. companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Canada companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Mexico companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Europe companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 UK companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Germany companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 France companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Spain companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Italy companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Denmark companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Sweden companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Norway companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Asia Pacific companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Japan companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 China companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 India companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Australia companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 South Korea companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Thailand companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Market participant categorization
  • Fig. 96 Companion Diagnostics market position analysis, 2023
  • Fig. 97 Strategic framework